图书馆订阅: Guest
医药载体系统评论综述

每年出版 6 

ISSN 打印: 0743-4863

ISSN 在线: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases

卷 35, 册 5, 2018, pp. 433-467
DOI: 10.1615/CritRevTherDrugCarrierSyst.2018024697
Get accessGet access

摘要

Intranasal drug delivery is emerging as a reliable and promising pathway to deliver a wide range of therapeutic agents including small and large molecules, peptides and proteins, genes to the central nervous system for the treatment of brain diseases such as Alzheimer's disease, Parkinson’s disease, depression, migraine, schizophrenia, and glioma. This presents noninvasive entry into the brain via direct nose-to-brain and/or indirect nose-to-blood-to-brain routes. Several nanocarrier-based strategies have been developed to transport therapeutic agents to the brain including nanoparticles, liposomes, and exosomes following intranasal delivery. However, the multiple barriers in nose-to-brain route — including rapid mucociliary clearance in the nasal cavity, enzyme degradation, and the blood–brain barrier (BBB) — pose serious challenges to brain-targeted drug delivery. Hence, very limited translation from the laboratory to the clinic has been achieved. The present review highlights the surface modification of nanocarriers with different strategies devoted to facilitate nose-to-brain delivery: prolonging retention time in the nasal cavity, improving penetration ability, and promoting brain targeting with ligands. Additionally, in vitro blood–brain barrier models, influencing an efficient study on intranasal delivery of therapeutics into the brain through indirect nose-to-blood-to-brain pathway, is discussed.

对本文的引用
  1. Agrahari Vibhuti, Burnouf Pierre-Alain, Burnouf Thierry, Agrahari Vivek, Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential, Advanced Drug Delivery Reviews, 148, 2019. Crossref

  2. Zhu Qingwei, Ling Xiaozheng, Yang Yunlong, Zhang Juntao, Li Qing, Niu Xin, Hu Guowen, Chen Bi, Li Haiyan, Wang Yang, Deng Zhifeng, Embryonic Stem Cells‐Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy, Advanced Science, 6, 6, 2019. Crossref

  3. Zhang Lei, Zhao Penghe, Yue Caiping, Jin Zhaokui, Liu Qiong, Du Xiubo, He Qianjun, Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease, Biomaterials, 197, 2019. Crossref

  4. Kim Do Hee, Kothandan Vinoth Kumar, Kim Hye Won, Kim Ki Seung, Kim Ji Young, Cho Hyeon Jin, Lee Yong-kyu, Lee Dong-Eun, Hwang Seung Rim, Noninvasive Assessment of Exosome Pharmacokinetics In Vivo: A Review, Pharmaceutics, 11, 12, 2019. Crossref

  5. Ghadiri Maliheh, Young Paul, Traini Daniela, Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes, Pharmaceutics, 11, 3, 2019. Crossref

  6. Kim Kyoungnam, Hwang Hee Sook, Shim Min Suk, Cho Yong-Yeon, Lee Joo Young, Lee Hye Suk, Kang Han Chang, Controlling complexation/decomplexation and sizes of polymer-based electrostatic pDNA polyplexes is one of the key factors in effective transfection, Colloids and Surfaces B: Biointerfaces, 184, 2019. Crossref

  7. Rehman Saleha, Nabi Bushra, Zafar Ameeduzzafar, Baboota Sanjula, Ali Javed, Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?, Expert Opinion on Drug Delivery, 16, 12, 2019. Crossref

  8. Xu Yingqian, Wei Lijia, Wang Hui, Progress and perspectives on nanoplatforms for drug delivery to the brain, Journal of Drug Delivery Science and Technology, 57, 2020. Crossref

  9. Panek Małgorzata, Kawalec Paweł, Pilc Andrzej, Lasoń Władysław, Developments in the discovery and design of intranasal antidepressants, Expert Opinion on Drug Discovery, 15, 10, 2020. Crossref

  10. Tan Madeleine S. A., Parekh Harendra S, Pandey Preeti, Siskind Dan J., Falconer James R., Nose-to-brain delivery of antipsychotics using nanotechnology: a review, Expert Opinion on Drug Delivery, 17, 6, 2020. Crossref

  11. Bicker Joana, Fortuna Ana, Alves Gilberto, Falcão Amílcar, Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders, Current Pharmaceutical Design, 26, 5, 2020. Crossref

  12. Shringarpure Mihika, Gharat Sankalp, Momin Munira, Omri Abdelwahab, Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery, Expert Opinion on Drug Delivery, 18, 2, 2021. Crossref

  13. Panzarini Elisa, Mariano Stefania, Tacconi Stefano, Carata Elisabetta, Tata Ada Maria, Dini Luciana, Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders, Nanomaterials, 11, 1, 2020. Crossref

  14. Fonseca-Santos Bruno, Chorilli Marlus, The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems, International Journal of Pharmaceutics, 589, 2020. Crossref

  15. Zorkina Yana, Abramova Olga, Ushakova Valeriya, Morozova Anna, Zubkov Eugene, Valikhov Marat, Melnikov Pavel, Majouga Alexander, Chekhonin Vladimir, Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations, Molecules, 25, 22, 2020. Crossref

  16. Su Yu, Sun Bixi, Gao Xiaoshu, Liu Shuwen, Hao Rubin, Han Bing, Chitosan Hydrogel Doped with PEG-PLA Nanoparticles for the Local Delivery of miRNA-146a to Treat Allergic Rhinitis, Pharmaceutics, 12, 10, 2020. Crossref

  17. Su Yu, Sun Bixi, Gao Xiaoshu, Dong Xinyue, Fu Lanbo, Zhang Yingxin, Li Zhulin, Wang Yue, Jiang Hongyu, Han Bing, Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases, Frontiers in Pharmacology, 11, 2020. Crossref

  18. 邓 爱林, Nanoparticles Administered through Nasal Cavity and Its Progress in the Treatment of Brain Diseases, Hans Journal of Biomedicine, 11, 02, 2021. Crossref

  19. Laffleur Flavia, Bauer Bettina, Progress in nasal drug delivery systems, International Journal of Pharmaceutics, 607, 2021. Crossref

  20. Hayes Sarah H., Liu Qingfan, Selvakumaran Sureka, Haney Matthew J., Batrakova Elena V., Allman Brian L., Walton Paul A., Kiser Patti, Whitehead Shawn N., Brain Targeting and Toxicological Assessment of the Extracellular Vesicle-Packaged Antioxidant Catalase-SKL Following Intranasal Administration in Mice, Neurotoxicity Research, 39, 5, 2021. Crossref

  21. Li Jie, Tan Tiantian, Zhao Liping, Liu Mengmeng, You Yu, Zeng Yiying, Chen Dajing, Xie Tian, Zhang Lele, Fu Chaomei, Zeng Zhaowu, Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review, ACS Applied Bio Materials, 3, 9, 2020. Crossref

  22. Asefy Zahra, Hoseinnejhad Sirus, Ceferov Zaker, Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment, Neurological Sciences, 42, 7, 2021. Crossref

  23. Peswani Sajnani Shilpa Lekhraj, Zhang Yunyue, Vllasaliu Driton, Exosome-based therapies for mucosal delivery, International Journal of Pharmaceutics, 608, 2021. Crossref

  24. Pandey Abhijeet, Nikam Ajinkya, Basavraj Shreya, Mutalik Sadhana, Gopalan Divya, Kulkarni Sanjay, Padya Bharat, Fernandes Gasper, Mutalik Srinivas, Nose-to-brain drug delivery: Regulatory aspects, clinical trials, patents, and future perspectives, in Direct Nose-to-Brain Drug Delivery, 2021. Crossref

  25. Karthika Chenmala, Sureshkumar Raman, Zehravi Mehrukh, Akter Rokeya, Ali Faraat, Ramproshad Sarker, Mondal Banani, Kundu Milton Kumar, Dey Abhijit, Rahman Md. Habibur, Antonescu Angela, Cavalu Simona, Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells, Life, 12, 6, 2022. Crossref

  26. Zha Shuai, Wong Ka‐Leung, All Angelo H., Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain, Advanced Healthcare Materials, 11, 11, 2022. Crossref

  27. Moradi Fatemeh, Dashti Nasrin, Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review, Naunyn-Schmiedeberg's Archives of Pharmacology, 395, 2, 2022. Crossref

  28. Pandey Manju, Nose-to-Brain Targeted Drug Delivery Bypassing the Blood-Brain Barrier, in Advancements in Controlled Drug Delivery Systems, 2022. Crossref

  29. Badhe Ravindra V., Nipate Sonali S., Nasal Bioadhesive Drug Delivery Systems and Their Applications, in Bioadhesives in Drug Delivery, 2020. Crossref

  30. Lamptey Richard Nii Lante, Gothwal Avinash, Trivedi Riddhi, Arora Sanjay, Singh Jagdish, Synthesis and Characterization of Fatty Acid Grafted Chitosan Polymeric Micelles for Improved Gene Delivery of VGF to the Brain through Intranasal Route, Biomedicines, 10, 2, 2022. Crossref

  31. Wu Yu, Rakotoarisoa Miora, Angelov Borislav, Deng Yuru, Angelova Angelina, Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery, Nanomaterials, 12, 13, 2022. Crossref

  32. Karthika Chenmala, Najda Agnieszka, Klepacka Joanna, Zehravi Mehrukh, Akter Rokeya, Akhtar Muhammad Furqan, Saleem Ammara, Al-Shaeri Majed, Mondal Banani, Ashraf Ghulam Md., Tagde Priti, Ramproshad Sarker, Ahmad Zubair, Khan Farhat S., Rahman Md. Habibur, Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach, Molecules, 27, 14, 2022. Crossref

  33. Gratpain Viridiane, Mwema Ariane, Labrak Yasmine, Muccioli Giulio G., van Pesch Vincent, des Rieux Anne, Extracellular vesicles for the treatment of central nervous system diseases, Advanced Drug Delivery Reviews, 174, 2021. Crossref

  34. Wang Julie Tzu‐Wen, Rodrigo Ana C., Patterson Anna K., Hawkins Kirsten, Aly Mazen M. S., Sun Jia, Al Jamal Khuloud T., Smith David K., Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self‐Healing Supramolecular Gel, Advanced Science, 8, 14, 2021. Crossref

  35. Formica María L., Real Daniel A., Picchio Matías L., Catlin Elise, Donnelly Ryan F., Paredes Alejandro J., On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles, Applied Materials Today, 29, 2022. Crossref

  36. Zhang Yong-Bo, Xu Dong, Bai Lu, Zhou Yan-Ming, Zhang Han, Cui Yuan-Lu, A Review of Non-Invasive Drug Delivery through Respiratory Routes, Pharmaceutics, 14, 9, 2022. Crossref

  37. Oraki Kohshour Mojtaba, Papiol Sergi, Delalle Ivana, Rossner Moritz J., Schulze Thomas G., Extracellular vesicle approach to major psychiatric disorders, European Archives of Psychiatry and Clinical Neuroscience, 2022. Crossref

  38. Afzal Obaid, Altamimi Abdulmalik S. A., Nadeem Muhammad Shahid, Alzarea Sami I., Almalki Waleed Hassan, Tariq Aqsa, Mubeen Bismillah, Murtaza Bibi Nazia, Iftikhar Saima, Riaz Naeem, Kazmi Imran, Nanoparticles in Drug Delivery: From History to Therapeutic Applications, Nanomaterials, 12, 24, 2022. Crossref

  39. Patel Darshana, Thakkar Hetal, Formulation considerations for improving intranasal delivery of CNS acting therapeutics, Therapeutic Delivery, 13, 7, 2022. Crossref

  40. Qiu Ziyi, Yu Zhenhua, Xu Ting, Wang Liuyou, Meng Nanxin, Jin Huawei, Xu Bingzhe, Novel Nano-Drug Delivery System for Brain Tumor Treatment, Cells, 11, 23, 2022. Crossref

  41. Shaik Nazma., Y Prasanth., Nanocarriers and their Types for Targeted Drug Delivery, International Journal of Pharmaceutical Sciences Review and Research, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain